PPARG and central nervous system cancer: Also, our earlier study showed additive effects of celecoxib (COX-2 inhibitor) and Fmoc-L-Leucine (PPARγ agonist) conjugated with biotinylated PAMAM G3 dendrimer in glioma and squamous cell carcinoma in vitro [39].